Identification | More | [Name]
ETHYL 5-BENZYLOXYINDOLE-2-CARBOXYLATE | [CAS]
37033-95-7 | [Synonyms]
5-BENZYLOXY-2-CARBETHOXYINDOLE 5-BENZYLOXYINDOLE-2-CARBOXYLIC ACID ETHYL ESTER 5-BENZYLOXYINDOLE ETHYL-2-CARBOXYLATE 5-(PHENYLMETHOXY)-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER BUTTPARK 97\57-93 ETHYL 5-(BENZYLOXY)-1H-INDOLE-2-CARBOXYLATE ETHYL 5-BENZYLOXYINDOLE-2-CARBOXYLATE 1H-Indole-2-carboxylic acid, 5-(phenylmethoxy)-, ethyl ester 5-benzyloxyindole-2-carboxylic acid*ethyl ester C ethyl 5-(phenylmethoxy)-1H-indole-2-carboxylate 5-BENZYLOXYINDOLE-2-CARBOXYLIC ACIDETHYL ESTER CRY BENZYLOXY INDOLECARBOXYLIC ACID ETHYL ESTER 5-BENZYLOXYINDOLE-3-CARBOXYLICACIDETHYLESTER 5-BENZYLOXYINDOLE ETHYL-2-CARBOXYLATE 97% 5-BzlO-ICA-OEt 5-(Benzyloxy)-1H-indole-2-carboxylic acid ethyl ester | [EINECS(EC#)]
253-322-0 | [Molecular Formula]
C18H17NO3 | [MDL Number]
MFCD00022702 | [Molecular Weight]
295.33 | [MOL File]
37033-95-7.mol |
Chemical Properties | Back Directory | [Melting point ]
163 °C | [Boiling point ]
481.4±30.0 °C(Predicted) | [density ]
1.225±0.06 g/cm3(Predicted) | [storage temp. ]
−20°C
| [form ]
powder | [pka]
14?+-.0.30(Predicted) | [BRN ]
281129 | [InChI]
InChI=1S/C18H17NO3/c1-2-21-18(20)17-11-14-10-15(8-9-16(14)19-17)22-12-13-6-4-3-5-7-13/h3-11,19H,2,12H2,1H3 | [InChIKey]
DCIFXYFKVKDOLL-UHFFFAOYSA-N | [SMILES]
N1C2=C(C=C(OCC3=CC=CC=C3)C=C2)C=C1C(OCC)=O | [CAS DataBase Reference]
37033-95-7(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Safety Statements ]
S22:Do not breathe dust . S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [HS Code ]
29339900 |
Hazard Information | Back Directory | [Uses]
Reactant for preparation of indolyl ethanones as indoleamine 2,3-dioxygenase inhibitors 1 Reactant for preparation of histamine H3 receptor inverse agonists 2 Reactant for preparation of PPAR-γ binding agents with potential application to the treatment of osteoporosis 3 Reactant for preparation of Nonpeptide glycoprotein IIB/IIIA inhibitors 4 |
|
|